Effect of diazinon and / or praziquantel on selected protein aspects in healthy and Schistosoma mansoni infected mice

The effect of 1/20 LD50 diazinon given orally to healthy and Schistosomiasis mansoni infected mice for 5-9 successive days and 17 weeks coupled with a therapeutic dose [2x500 mg/kg b. Wt.] of praziquantel two weeks before sacrificing. The results showed insignificant differences obtained from total proteins, albumin, globulins and albumin/globulin ratio. However, significant differences were revealed from alpha 1, alpha 2, beta 1, beta 2 and gamma-globulins in addition to plasma ceruloplasmin. Diazinon changed the levels of alpha 2, beta 1 and gamma-globulins, while diazinon coupled with schistosomiasis affected the levels of most of the studies parameters

Biochemical changes after subchronic and chronic interaction of Schistosoma mansoni infection in Swiss albino mice with two specific compounds

The effects of diazinon [DZN] and/or praziquantel [PZQ] on the levels of plasma triiodothyronine [T3] and thyroxine [T4], activities of brain acetylcholinesterase [AchE] and liver alanine aminotransferase [ALT] in addition to blood reduced glutathione [GSH] in healthy and Schistosoma mansoni [Sm] infected mice were investigated after 9 and 17 weeks of either infection or intoxication with DZN. Triiodothyronine showed significant differences among the different treatments. The group of mice treated with PZQ showed the highest levels of T3 at both time intervals. Thyroxine level showed significant differences between the two time intervals. The lowest levels of T4 were observed in the infected-PZQ grown at week 17. The maximum inhibition of brain AchE activity was noticed in DZN-PZQ treated group after 9 and 17 weeks

Effect of extracorporeal shock wave lithotripsy on liver function

23 Egyptian patients were subjected to analysis of various liver functional parameters before, one day and one month after treatment with extracorporeal shock wave lithotripsy [ESWL]. Liver function was evaluated by measuring aspartate transaminase [AST], alanine transaminase [ALT], alkaline phosphatase [ALP] and prothrombin concentration. The liver enzymes were not influenced by ESWL as based on unchanged serum levels of AST, ALT and ALP. Post treatment prothrombin concentration was not significantly different from those before treatment or controls except one day after ESWL. Since prothrombin concentration is a sensitive test for liver dysfunction, it was affected by ESWL and the reduction in its value after the first day indicates mild hepatic injury which was recoverable